1h Free Analyst Time
The positron emission tomography market is forecasted to grow by USD 725.97 million during 2023-2028, accelerating at a CAGR of 5.97% during the forecast period. The report on the positron emission tomography market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic conditions worldwide, the rising number of new product launches by prominent vendors, and the growing number of M&A activities.
The positron emission tomography market is segmented as below:
By Type
- PET-CT
- PET-MRI
By Application
- Oncology
- Cardiology
- Neurology
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the positron emission tomography market covers the following areas:
- Positron emission tomography market sizing
- Positron emission tomography market forecast
- Positron emission tomography market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the global positron emission tomography market: Bracco Spa, Canon Inc., Cardinal Health Inc., CellSight Technologies Inc., CMR Naviscan Corp., GE Healthcare Technologies Inc., Jubilant Pharmova Ltd., Koninklijke Philips N.V., Mediso Ltd., MinFound Medical Systems Co. Ltd., Modus Medical Devices Inc., Neusoft Corp., Novartis AG, PETsys Electronics SA, Positron Corp., Radiology Oncology Systems Inc., RefleXion Medical Inc., Shimadzu Corp., Siemens Healthineers AG, and Yangzhou Kindsway Biotech Co. Ltd.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advancements in pet scanners.'
According to the report, one of the major drivers for this market is the increasing prevalence of chronic conditions worldwide.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bracco Spa
- Canon Inc.
- Cardinal Health Inc.
- CellSight Technologies Inc.
- CMR Naviscan Corp.
- GE Healthcare Technologies Inc.
- Jubilant Pharmova Ltd.
- Koninklijke Philips N.V.
- Mediso Ltd.
- MinFound Medical Systems Co. Ltd.
- Modus Medical Devices Inc.
- Neusoft Corp.
- Novartis AG
- PETsys Electronics SA
- Positron Corp.
- Radiology Oncology Systems Inc.
- RefleXion Medical Inc.
- Shimadzu Corp.
- Siemens Healthineers AG
- Yangzhou Kindsway Biotech Co. Ltd.